Luteolin Improves Perivascular Adipose Tissue Profile and Vascular Dysfunction in Goto-Kakizaki Rats

Area of Science:

• Biomedical Science
• Metabolic Research
• Vascular Biology

Background:

• Type 2 diabetes mellitus (T2DM) is associated with endothelial dysfunction and vascular complications.
• Perivascular adipose tissue (PVAT) plays a role in regulating vascular tone and inflammation.
• Nonobese T2DM models like Goto-Kakizaki (GK) rats offer insights into disease mechanisms.

Purpose of the Study:

• To investigate the effects of luteolin on metabolic parameters, vascular reactivity, and PVAT in GK rats.
• To assess luteolin's impact on endothelial function, oxidative stress, and inflammation in a T2DM model.
• To determine if luteolin can ameliorate vascular complications associated with T2DM.

Main Methods:

• GK rats and Wistar controls were treated with luteolin (10 mg/kg/day) or vehicle for 2 months.
• Metabolic parameters (adiposity, lipids, glucose) and glucose/insulin tolerance were assessed.
• Vascular reactivity, oxidative stress, glycation, and PVAT markers (CRP, CCL2, nitrotyrosine) were analyzed.

Main Results:

• Luteolin significantly improved endothelial-dependent relaxation in GK rats, reducing impairment from 47-65% to 22-29%.
• Vascular oxidative stress and advanced glycation end-products were normalized by luteolin treatment.
• Luteolin administration rescued PVAT anti-contractile action and reversed its proinflammatory/pro-oxidant phenotype.

Conclusions:

• Luteolin effectively ameliorates endothelial dysfunction in a nonobese model of type 2 diabetes.
• The compound demonstrates therapeutic potential for managing vascular complications in T2DM.
• Luteolin's benefits extend to improving metabolic parameters and PVAT function in diabetic rats.